ATNF - smelling a pump - high risk!180 Life Sciences Corp is a clinical-stage biotechnology company. It is focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation and fibrosis by employing innovative research, and, where appropriate, combination therapy.
Disclaimer: This content is for infor
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−6.3831 USD
−6.17 M USD
0.00 USD
916.07 K
About 180 Life Sciences Corp.
Sector
Industry
CEO
Blair Jordan
Website
Headquarters
Palo Alto
Founded
2016
FIGI
BBG00H1CP0B4
180 Life Sciences Corp. operates as a clinical-stage biotechnology company, which engages in the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University. The company was founded by Marc Feldmann, Lawrence J. Steinman, and Jonathan B. Rothbard on September 7, 2016 and is headquartered in Palo Alto, CA.
ATnF Had a pretty sweet uptrend here, something to watch as buyers have been strong. Previous reistance was at 4.88 areas to 4.86. We backtest that twice so far today and although 5$ was a reistance previously, it seems since we broke higher today it has now become an easy clearing level. The newest rei
ATNF | Is My Math Off? | LONG1180 Life Sciences Corp., a clinical-stage biotechnology company, develops therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. Its product development platforms include fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which is un
could this be worth over $3? (ATNF)its not much of an uptrend, but the daily is enjoying a sizeable bounce so far, qnd im looking for this to continue into noon or maybe 1pm.
the RHS i have mapped out was not obvious until this morning as we did not clearly break the downtrend with our right shoulder. normally this invalidates the pa
Very good deal with High risk!!!The action picked up on a wave of news about the filing of medical approvals. Resistance ahead is 6.50. If it breaks through, there is a chance to go as high as 10.70 Upside:90%!
❤️ If you find this helpful and want more FREE forecasts in TradingView
. . . . . Please show your support back,
. . . .
ATNF ReversalATNF has made higher lows since it gapped down in mid August. The price is still oversold with an RSI just under 50.
The most recent candles have tested the 200MA and the .23 fib levels. Yesterday's candle made an inside bar which is a bullish signal in an uptrend.
Looking for the price to move
ATNF 180 Life Sciences Private PlacementATNF 180 Life Sciences Corp. received a Private Placement of $15.0 million for 2,500,000 shares of common stock at a combined purchase price of $6.00 per share and accompanying warrant at an exercise price of $7.50 per share and will expire five years from the date of issuance.
I consider this 7.5u
See all ideas
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Related stocks
Frequently Asked Questions
The current price of ATNF is 0.8985 USD — it has increased by 2.43% in the past 24 hours. Watch 180 Life Sciences Corp. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange 180 Life Sciences Corp. stocks are traded under the ticker ATNF.
ATNF stock has risen by 19.80% compared to the previous week, the month change is a −16.03% fall, over the last year 180 Life Sciences Corp. has showed a −38.88% decrease.
ATNF reached its all-time high on Apr 12, 2021 with the price of 4,957.2140 USD, and its all-time low was 0.6578 USD and was reached on Apr 9, 2025. View more price dynamics on ATNF chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
ATNF stock is 10.70% volatile and has beta coefficient of 1.48. Track 180 Life Sciences Corp. stock price on the chart and check out the list of the most volatile stocks — is 180 Life Sciences Corp. there?
Today 180 Life Sciences Corp. has the market capitalization of 1.78 M, it has increased by 18.45% over the last week.
Yes, you can track 180 Life Sciences Corp. financials in yearly and quarterly reports right on TradingView.
180 Life Sciences Corp. is going to release the next earnings report on May 28, 2025. Keep track of upcoming events with our Earnings Calendar.
ATNF net income for the last quarter is −4.27 M USD, while the quarter before that showed −836.72 K USD of net income which accounts for −410.74% change. Track more 180 Life Sciences Corp. financial stats to get the full picture.
No, ATNF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 21, 2025, the company has 3 employees. See our rating of the largest employees — is 180 Life Sciences Corp. on this list?
Like other stocks, ATNF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade 180 Life Sciences Corp. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So 180 Life Sciences Corp. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating 180 Life Sciences Corp. stock shows the sell signal. See more of 180 Life Sciences Corp. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.